MedPath

广东红珊瑚药业有限公司

Ownership
-
Established
1998-07-27
Employees
-
Market Cap
-
Website
http://www.hongshanhu.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

NMPA:14

Drug Approvals

Oseltamivir Phosphate for Suspension

Product Name
磷酸奥司他韦干混悬剂
Approval Number
国药准字H20253144
Approval Date
Jan 14, 2025
NMPA

益气维血片

Approval Number
国药准字Z20050186
Approval Date
Jul 5, 2021
NMPA

Lysozyme Buccal Tablets

Product Name
溶菌酶含片
Approval Number
国药准字H20056459
Approval Date
Aug 4, 2020
NMPA

益气维血颗粒

Approval Number
国药准字Z10950034
Approval Date
Aug 4, 2020
NMPA

养肾补血颗粒

Approval Number
国药准字B20020701
Approval Date
Jul 1, 2020
NMPA

精肝颗粒

Approval Number
国药准字B20020809
Approval Date
Jul 1, 2020
NMPA

益气维血胶囊

Approval Number
国药准字Z20050700
Approval Date
Jul 1, 2020
NMPA

惠普安丽牌天然胡萝卜素软胶囊

Approval Number
国食健注G20200636
Approval Date
Jun 17, 2020
NMPA

惠普安丽牌维生素AD软胶囊

Approval Number
国食健注G20170909
Approval Date
Jul 21, 2017
NMPA

惠普安丽牌叶酸铁片

Approval Number
国食健注G20170310
Approval Date
Jul 7, 2017
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.